Pulmonary tuberculosis

ICD-9: 011.xx

REPORTABLE DISEASE

Description

Pulmonary tuberculosis (TB) is a slowly developing bacterial lung infection characterized by progressive necrosis of lung tissue. An inflammatory response begins with phagocytosis. Growths of inflamed, granular-appearing tissue (granulomas) form and, when they calcify, leave lesions that may be visible on an x-ray. The lymph and blood generally are affected.

Pulmonary TB is a common cause of death in the world. The arrival of nearly 400,000 immigrants and over 50,000 refugees per year from overseas contributes to the rise of TB in the United States. The incidence of TB also is increasing due to homelessness, substance abuse, and HIV infection – all related to individuals who are less likely to receive adequate medical attention. In general, TB is more common among elderly persons, the urban poor, and members of minority groups.

READ:   Pleural effusion

Etiology

Pulmonary TB is caused by Mycobacterium tuberculosis. The infected individual’s immune system usually is able to wall the bacteria into a tubercle or tiny nodule. The bacteria can lie dormant for years and then reactivate and spread when conditions are favorable. The disease is transmitted in aerosol droplets exhaled by infected individuals. Note: Although the lungs are the organs most commonly infected, the bacteria can infect other parts of the body as well.

Signs and Symptoms

Pulmonary TB may be asymptomatic. The onset generally is insidious. When symptoms are present, they are often vague and may include cough, lassitude, malaise, fatigability, night sweats, anorexia, afternoon fever, weight loss, pleuritic chest pain, hemoptysis, and wheezing.

READ:   Anthracosis

Diagnostic Procedures

Anteroposterior x-ray of a patient diagnosed with advanced bilateral pulmonary tuberculosis

FIGURE. Anteroposterior x-ray of a patient diagnosed with advanced bilateral pulmonary tuberculosis. (Centers for Disease Control and Prevention, 1972.)

A thorough physical examination, chest x-ray or CT scan, bronchoscopy, and positive tuberculin test often confirm the diagnosis. The tuberculin test of choice is the Mantoux test, which consists of an intradermal injection of a purified protein derivative (PPD) of the tuberculin bacillus. The TB skin test cannot determine if the disease is active. This determination requires sputum analysis (smear and culture) in the laboratory. The sensitive PCR (polymerase chain reaction) test can detect the genetic material of the bacteria, usually within a few days. The bacteria may be identified in the sputum, urine, body fluids, or tissues of the client. Pulmonary and pleural biopsies may be ordered.

READ:   Thrush

Treatment

Drug therapy is indicated in every case of pulmonary TB. There are many TB drugs, however, and these can be used in a number of different ways. To prevent the development of resistance, TB drugs are administered in combinations of two or more (usually four) in most instances. Prolonged use of about 6 months is essential. Bed rest and isolation are indicated until the person is strong enough to resume activities.

Complementary Therapy

A whole-foods and nutritious diet combined with vitamin supplements can be helpful. Enhancing the body’s immune response with fresh air, rest, light exercise, and relaxation will prove beneficial.

CLIENT COMMUNICATION

READ:   Respiratory mycoses

Teach clients to cough and sneeze into tissues and to properly dispose of all secretions. Remind them of the importance of taking all their medications. Teach family members about the infectious nature of the disease and proper medication regimen. Individuals exposed to someone with pulmonary TB disease should contact their primary care provider or local health department about getting a TB skin test.

Prognosis

The prognosis for an individual with active pulmonary TB is good if the disease is detected early and if the client follows the prescribed regimen of drug therapy. However, if strains of bacteria are resistant to two or more of the major antituberculosis agents, mortality rates increase.

READ:   Respiratory alkalosis (Hypocapnia)

Prevention

Preventive measures include proper infection control, tuberculin testing of persons known to have been in close contact with infected persons, and treatment of individuals reacting to the tuberculin testing. Generally, a person with a positive tuberculin reaction is put on 1 year of isoniazid prophylactically. Use of the bacille Calmette-Guerin (bCG) vaccination should be considered only for very select persons who meet specific criteria and in consultation with a TB expert.

Sudden infant death syndrome ICD-9: 789.0 Description Sudden infant death syndrome (SIDS) is the completely unexpected and unexplained death of an apparently normal and healthy infant, usually at ages 10 to 12 weeks. Most often, the death occurs when the infant is sleeping. SIDS occurs more frequently in male than in female infants, in premature infants, and during the winter months. The number of deaths has been greatly reduced in the last 2 decades, but it is a leading cause of death in infants ages 1 to 12 months. Approximately 2500 infants die each year. Etiology The cause is unknown, but several possibilities have been suggested, including mechanical suffocation, prolonged apnea, lack of a component of the vitamin B complex essential for the metabolism of fat and carbohydrates (biotin) in the diet, an unknown virus, immunoglobulin abnormalities, a defect in the respiratory mucosal defense, or an anatomically abnormal larynx. Signs and Symptoms There are no premonitory signs and symptoms. The i...
Pulmonary edema ICD-9: 514 Description Pulmonary edema is a diffuse extravascular accumulation of fluid in the pulmonary tissues and air spaces. Most commonly, it represents the projection of cardiac disease processes, such as atherosclerosis, hypertension, or valvular disease. The condition is usually a direct consequence of left ventricular failure. Pulmonary edema can occur as a chronic condition, or it can develop quickly. Pulmonary edema is considered a medical emergency. Etiology When the alveoli fill with fluid instead of air, preventing oxygen from being absorbed into the bloodstream, more blood is added to the pulmonary circulation than can be adequately removed. In addition to the cardiac problems already mentioned, pulmonary edema may also be the result of lung infections, living at high altitudes, smoking, certain toxin exposure, pneumonia, and acute respiratory diseases. Signs and Symptoms The onset of pulmonary edema frequently occurs at night, after the person has been l...
Silicosis ICD-9: 502 Description Silicosis, also known as grinder’s disease and potter’s rot, results from the inhalation of crystalline silica dust. Silica is a common mineral found naturally in sand and rock. Silica scars lungs and creates small, discrete nodules in the upper lobes of the lungs. As the disease advances, a dense fibrosis of the lungs develops, and emphysema with respiratory impairment may result. The disease is chronic and progressive. Etiology Silica exposure is common in mines and quarries and in a number of occupations, such as sandblasting, foundry work, ceramics, and glassmaking. The occupations most prone to silica exposure are mining, drilling, blasting, grinding, and abrasive manufacturing. Required exposure varies from 2 to 30 years; the average is 10 years. Signs and Symptoms The disease may be asymptomatic even though x-rays exhibit evidence of nodule formation. Dyspnea on exertion generally is the first symptom. A chronic dry cough that later turns p...
Atelectasis ICD-9: 518.0 Description Atelectasis is a collapsed or an airless condition of all or part of a lung that allows unoxygenated blood to pass unchanged through the area; this produces hypoxia. The condition may be acute or chronic. Etiology The condition may be caused by obstruction of the lung by foreign matter, mucus plugs, or excessive secretion. It is seen in many clients with COPD or cystic fibrosis and those who smoke heavily. Compression of the lung by tumors, aneurysms, enlarged lymph nodes, or pneumothorax also may cause lung collapse (see Pneumothorax). Atelectasis is sometimes a complication of abdominal surgery or a general consequence of postoperative immobilization. Signs and Symptoms Chronic atelectasis may be marked only by the gradual onset of dyspnea. Acute atelectasis typically includes marked dyspnea, cyanosis, fever, tachycardia, anxiety, and diaphoresis (profuse sweating). There may be a decrease in chest motion on the affected side. Chronic atelecta...
EPIGLOTTITIS ICD-9: 464.31 Description Epiglottitis occurs when the epiglottis covering the windpipe swells and blocks the flow of air into the lungs. It is life-threatening. Etiology Infection with Haemophilus influenzae type b (Hib) is the most common cause, followed by burns from hot liquids and direct injury to the throat. Other bacteria and viruses that cause epiglottitis are pneumococcus; streptococcus A, B, and C; Candida albicans; and varicella zoster. Swallowing a foreign object and smoking crack cocaine and heroin may also cause epiglottitis. Signs and Symptoms Onset of symptoms is sudden. Likely symptoms include sore throat, painful swallowing, fever, drooling, hoarseness, dyspnea, and cyanosis. Diagnostic Procedures Once the airway is open and the condition is stable, the throat is examined with a flexible fiberoptic tube. A blood test and throat culture are likely taken to establish the cause of any infection. Treatment The first priority is to establish a c...